Nafamostat
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | IV |
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
81525-10-2 ![]() |
PubChem (CID) | 4413 |
IUPHAR/BPS | 4262 |
ChemSpider |
4260 ![]() |
UNII |
Y25LQ0H97D ![]() |
KEGG |
D01670 ![]() |
Chemical and physical data | |
Formula | C19H17N5O2 |
Molar mass | 347.37 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
![]() ![]() |
Nafamostat (INN), a synthetic serine protease inhibitor, is an anticoagulant. Nafamostat is formulated with HCl salt due to its basic tendencies. This is a fast-acting proteolytic inhibitor and used during hemodialysis to prevent the proteolysis of fibrinogen into fibrin.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.